(Q36082480)

English

Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Quirino Lai

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Fabio Melandro

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Rafael S Pinheiro

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Andrea Donfrancesco

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Bashir A Fadel

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Giovanni B Levi Sandri

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Massimo Rossi

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Pasquale B Berloco

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Fabrizio M Frattaroli

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

27 June 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

International Journal of Hepatology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

893103

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Gene-expression signature of vascular invasion in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Building a comprehensive genomic program for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Differential effects of vitamin K1 on AFP and DCP levels in patients with unresectable HCC and in HCC cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Cancer gene discovery in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Molecular targeted therapies in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Novel advancements in the management of hepatocellular carcinoma in 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

2 October 2017

Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

11 July 2018

Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

11 July 2018

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

11 July 2018

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

11 July 2018

Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Predictive factors of recurrence of hepatocellular carcinoma after liver transplantation: a multivariate analysis.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

AFP in OLT for HCC?: Another shadow on the cave wall: Comment on "Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer".

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

HCC in living donor liver transplantation: can we expand the Milan criteria?

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

The Milan criteria: no room on the metro for the king?

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391901

23 September 2018

Role of Alpha-Fetoprotein in Selection of Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation: Must we Reconsider it?

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the Biomarker Combined Japan Integrated Staging Score

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F893103

21 January 2018

Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor markers after radiofrequency ablation therapy for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular-based prediction of early recurrence in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some patients with HCC haven't abnornormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor marker levels before and after curative treatment of hepatocellular carcinoma as predictors of patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation for hepatocellular carcinoma: Hangzhou experiences

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2012/893103

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36082480&oldid=1991080905"